Zoltan Szekanecz - Selected Publications#

1. Kloppenburg M, Kroon FPB, Blanco FJ, Doherty M, Dziedzic KS, Greibrokk E, Haugen IK, Herrero-Beaumont G, Jonsson H, Kjeken I, Maheu E, Ramonda R, Ritt MJPF, Smeets W, Smolen JS, Stamm T, Szekanecz Z, Wittoek R, Carmona L. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis 78: 16-24, 2019. (Q1; IF 14.299; WoS citation 19)

2. Póliska S, Besenyei T, Végh E, Hamar A, Pusztai A, Váncsa A, Bodnár N, Szamosi S, Csumita M, Kerekes G, Szabó Z, Nagy Z, Szűcs G, Szántó S, Zahuczky G, Nagy L, Szekanecz Z. Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis. Arthritis Res Ther 21: 94, 2019. (Q1; IF 4.148, WoS citation 3)

3. Roodenrijs NMT, de Hair MJH, van der Goes MC, Jacobs JWG, Welsing PMJ, van der Heijde D, Aletaha D, Dougados M, Hyrich KL, McInnes IB, Mueller-Ladner U, Senolt L, Szekanecz Z, van Laar JM, Nagy G; EULAR Task Force. Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey. Ann Rheum Dis 77: 1705-1709, 2018. (Q1; IF 14.299; WoS citation 6)

4. Szentpétery Á, Horváth Á, Gulyás K, Pethő Z, Bhattoa HP, Szántó S, Szücs G, FitzGerald O, Schett O, Szekanecz Z. Effects of targeted therapies on the bone in arthritides. Autoimmun Rev 16: 313-320, 2017 (Epub 2017 Jan 31) (Q1; IF 8.490; WoS citation 9)

5. Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Alvaro-Gracia JM, Bakkers M, Brodin N, Burmester GR, Codreanu C, Conway R, Dougados M, Emery P, Ferraccioli G, Fonseca J, Raza K, Silva-Fernandez L, Smolen JS, Skingle D, Szekanecz Z, Kvien TK, van der Helm-van Mil A, van Vollenhoven R. 2016 update of the EULAR recopmmendations for the management of early arthritis. Ann Rheum Dis 76: 948-959 (Epub 2016 Dec 15), 2017. (Q1; IF 12.384; WoS citation 113)

5. Juhász B, Gulyás K, Horváth Á, Pethő Z, Bhattoa HP, Váncsa A, Szekanecz É, Horváth C, Kocsis J, Horváth Z, Hodosi K, Szántó S, Szücs G, Szekanecz Z. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls. Osteoporosis Int 28: 1271-1277 (Epub 2016 Dec 10), 2017. (Q1; IF 3.445; WoS citation 2)

6. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DPM, Nurmohamed MT. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76: 17-28 (Epub 2016 Oct 3), 2017. (Q1; IF 12.384; WoS citation 284)

7. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb AG, Sidiropoulos P, Kitas G, Smulders YM, Soubrier MJ, Szekanecz Z, Sattar NG, Nurmohamed MT. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis69: 325-331, 2010 (Epub 2009 Sep 22)(Q1; IF 9.082; WoS citation 842)

8. Kerekes G*., Szekanecz Z*., Dér H, Sándor Z., Lakos G., Muszbek L., Csipő I., Sipka S., Seres I., Paragh G., Kappelmayer J., Szomják E., Veres K., Szegedi G., Shoenfeld Y., Soltész P.: Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.J Rheumatol 35: 398-406, 2008. (*Co-first authors: equal contribution.)(Q1; IF 3.282; WoS citation 123)

9. Szekanecz, Z., Haines, G.K., Lin, T.R., Harlow, L.A., Goerdt, S., Rayan, G, Koch, A.E.: Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2 and ICAM-3), and the MS-1 antigen in normal and diseased human synovia. Arthritis Rheum., 37:221-231, 1994. (Q1; IF 6.298; WoS citation 129)

10. Szekanecz, Z., Shah, M.R., Pearce, W.H., Koch, A.E.: Increased intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin. Exp. Immunol., 98:337-343, 1994. (Q1; IF 2.912; WoS citation 53)